BRADLEY FOSTER & SARGENT INC/CT Eli Lilly and Company Transaction History

BRADLEY FOSTER & SARGENT INC/CT portfolio value:

$6.74M
portfolio value

BRADLEY FOSTER & SARGENT INC/CT quarter portfolio value change:

-0.27%
quarter

Eli Lilly and Company 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase +0.07% 14 shares -14K $323.35 20.84K
Q2 2022 share Increase +2.27% 463 shares 921K $324.23 20.83K
Q1 2022 share Increase +22.94% 3.80K shares 1.25M $286.37 20.36K
Q4 2021 share Increase +3.92% 625 shares 893K $277.25 16.56K
Q3 2021 share Decrease -21.43% -4.34K shares -974K $230.3 15.94K
Q2 2021 share Decrease -2.17% -450 shares 782K $228.04 20.28K
Q1 2021 share Decrease -36.85% -12.1K shares -1.67M $184.81 20.73K
Q4 2020 share Decrease -0.15% -50 shares 677K $166.32 32.83K
Q3 2020 share Decrease -2.05% -690 shares 210K $145.05 32.88K
Q1 2020 share Increase +2.23% 734 shares 341K $134.64 33.57K
Q4 2019 share Increase +0.34% 111 shares 656K $126.91 32.84K
Q3 2019 share Decrease -0.50% -165 shares 16K $107.36 32.73K
Q2 2019 share Decrease -0.70% -231 shares -654K $105.74 32.89K
Q1 2019 share Increase +0.52% 172 shares 485K $123.17 33.13K
Q4 2018 share Decrease -9.77% -3.57K shares -106K $109.26 32.95K
Q3 2018 share 0.00% 0 shares 803K $100.8 36.52K
Q2 2018 share Decrease -0.27% -100 shares 283K $79.72 36.52K
Q1 2018 share Increase +3.16% 1.12K shares -165K $71.78 36.62K
Q4 2017 share Decrease -0.15% -53 shares -43K $77.79 35.50K
Q3 2017 share Decrease -0.74% -265 shares 94K $78.29 35.55K
Q2 2017 share Increase +1.14% 404 shares -31K $74.85 35.82K
Q1 2017 share Decrease -2.82% -1.02K shares 298K $76 35.41K
Q4 2016 share Increase +4.16% 1.45K shares -128K $66.02 36.44K
Q3 2016 share Decrease -0.28% -100 shares 45K $71.57 34.99K
Q2 2016 share 0.00% 0 shares 237K $69.79 35.09K
Q1 2016 share Decrease -2.45% -883 shares -504K $63.39 35.09K